Does TOFACITINIB Cause Therapeutic product effect decreased? 4,934 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 4,934 reports of Therapeutic product effect decreased have been filed in association with TOFACITINIB (XELJANZ XR). This represents 3.2% of all adverse event reports for TOFACITINIB.
4,934
Reports of Therapeutic product effect decreased with TOFACITINIB
3.2%
of all TOFACITINIB reports
895
Deaths
1,721
Hospitalizations
How Dangerous Is Therapeutic product effect decreased From TOFACITINIB?
Of the 4,934 reports, 895 (18.1%) resulted in death, 1,721 (34.9%) required hospitalization, and 1,177 (23.9%) were considered life-threatening.
Is Therapeutic product effect decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 4,934 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Therapeutic product effect decreased?
ADALIMUMAB (11,058)
METHOTREXATE (8,952)
ETANERCEPT (8,819)
ABATACEPT (7,256)
TOCILIZUMAB (7,208)
LEFLUNOMIDE (7,025)
HYDROXYCHLOROQUINE (6,450)
INFLIXIMAB (6,401)
RITUXIMAB (6,281)
GOLIMUMAB (5,478)
Which TOFACITINIB Alternatives Have Lower Therapeutic product effect decreased Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN